SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
18322388
Source:
http://linkedlifedata.com/resource/pubmed/id/18322388
Search
Subject
(
46
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0002395
,
umls-concept:C0025309
,
umls-concept:C0205177
,
umls-concept:C0449445
,
umls-concept:C1261322
,
umls-concept:C1280477
pubmed:issue
3-4
pubmed:dateCreated
2008-3-6
pubmed:abstractText
In a phase 2a clinical trial of AN1792 (Study 201), a potential immunotherapeutic agent for use in Alzheimer's disease (AD), approximately 6% of the treated AD patients (18/300) developed meningoencephalitis (ME).
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/101189034
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/AN-1792
,
http://linkedlifedata.com/resource/pubmed/chemical/Alzheimer Vaccines
,
http://linkedlifedata.com/resource/pubmed/chemical/Amyloid beta-Peptides
pubmed:status
MEDLINE
pubmed:issn
1660-2862
pubmed:author
pubmed-author:BlackRonald SRS
,
pubmed-author:EldridgeJohnJ
,
pubmed-author:GrundmanMichaelM
,
pubmed-author:HagenMichaelM
,
pubmed-author:PrideMichaelM
,
pubmed-author:SeubertPeterP
pubmed:copyrightInfo
2008 S. Karger AG, Basel
pubmed:issnType
Electronic
pubmed:volume
5
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
194-6
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:18322388-Alzheimer Disease
,
pubmed-meshheading:18322388-Alzheimer Vaccines
,
pubmed-meshheading:18322388-Amyloid beta-Peptides
,
pubmed-meshheading:18322388-Animals
,
pubmed-meshheading:18322388-Clinical Trials, Phase II as Topic
,
pubmed-meshheading:18322388-Humans
,
pubmed-meshheading:18322388-Immunotherapy, Active
,
pubmed-meshheading:18322388-Meningoencephalitis
,
pubmed-meshheading:18322388-Multicenter Studies as Topic
,
pubmed-meshheading:18322388-Pilot Projects
pubmed:year
2008
pubmed:articleTitle
Progress in the active immunotherapeutic approach to Alzheimer's disease: clinical investigations into AN1792-associated meningoencephalitis.
pubmed:affiliation
Wyeth Research, Collegeville, PA 19426, USA.
pubmed:publicationType
Journal Article
,
Review